«Given the growing epidemic of obesity,
diabetes, and NAFLD, this study
brings to the attention of policymakers, providers, pharmaceutical companies, payers, and patients the critical importance of understanding NAFLD and establishing a policy for
prevention, early detection, and effective therapy,» said Dr. Younossi.